Division of Neurosurgery, Creighton University Medical Center, Omaha, Nebraska, USA; Neurosurgery Research Inc., Norfolk, Virginia, USA.
Division of Neurosurgery, Creighton University Medical Center, Omaha, Nebraska, USA; Pinnacle Health, Cardiovascular Institute, Wormleysburg, Pennsylvania, USA.
World Neurosurg. 2022 Oct;166:e215-e236. doi: 10.1016/j.wneu.2022.06.149. Epub 2022 Jul 6.
Neurocritical management of aneurysmal subarachnoid hemorrhage focuses on delayed cerebral ischemia (DCI) after aneurysm repair.
This study conceptualizes the pathophysiology of cerebral ischemia and its management using a brain oxygen-directed protocol (intracranial pressure [ICP] control, eubaric hyperoxia, hemodynamic therapy, arterial vasodilation, and neuroprotection) in patients with subarachnoid hemorrhage, undergoing aneurysm clipping (n = 40).
The brain oxygen-directed protocol reduced Lbo (Pbto [partial pressure of brain tissue oxygen] <20 mm Hg) from 67% to 15% during acute brain attack (<24 hours of ictus), by increasing Pbto from 11.31 ± 9.34 to 27.85 ± 6.76 (P < 0.0001) and then to 29.09 ± 17.88 within 72 hours. Day-after-bleed, Fio change, ICP, hemoglobin, and oxygen saturation were predictors for Pbto during early brain injury. Transcranial Doppler ultrasonography velocities (>20 cm/second) increased at day 2. During DCI caused by territorial sonographic vasospasm (TSV), middle cerebral artery mean velocity (V) increased from 45.00 ± 15.12 to 80.37 ± 38.33/second by day 4 with concomitant Pbto reduction from 29.09 ± 17.88 to 22.66 ± 8.19. Peak TSV (days 7-12) coincided with decline in Pbto. Nicardipine mitigated Lbo during peak TSV, in contrast to nimodipine, with survival benefit (P < 0.01). Intravenous and cisternal nicardipine combination had survival benefit (Cramer Φ = 0.43 and 0.327; G = 28.32; P < 0.001). This study identifies 4 zones of Lbo during survival benefit (Cramer Φ = 0.43 and 0.3) TSV, uncompensated; global cerebral ischemia, compensated, and normal Pbto. Admission Glasgow Coma Scale score (not increased ICP) was predictive of low Pbto (β = 0.812, R = 0.661, F = 58.41; P < 0.0001) during early brain injury. Coma was the only credible predictor for mortality (odds ratio, 7.33/>4.8∗; χ = 7.556; confidence interval, 1.70-31.54; P < 0.01) followed by basilar aneurysm, poor grade, high ICP and Lbo during TSV. Global cerebral ischemia occurs immediately after the ictus, persisting in 30% of patients despite the high therapeutic intensity level, superimposed by DCI during TSV.
We propose implications for clinical practice and patient management to minimize cerebral ischemia.
在对动脉瘤性蛛网膜下腔出血进行神经重症管理时,重点关注的是动脉瘤修复后的迟发性脑缺血(DCI)。
本研究通过对行夹闭术的蛛网膜下腔出血患者(n=40)采用脑氧导向方案(颅内压[ICP]控制、适度高氧、血流动力学治疗、动脉血管扩张和神经保护),从概念上阐述了脑缺血的病理生理学及其治疗方法。
脑氧导向方案可降低急性脑损伤(发病后<24 小时)时的局部脑氧饱和度(Lbo,Pbto[脑组织氧分压]<20mmHg),将 Lbo 从 67%降低至 15%,具体方式为将 Pbto 从 11.31±9.34mmHg 升高至 27.85±6.76mmHg(P<0.0001),随后在 72 小时内进一步升高至 29.09±17.88mmHg。出血后第 1 天,Fio 变化、ICP、血红蛋白和氧饱和度是早期脑损伤时 Pbto 的预测因素。经颅多普勒超声(TCD)流速在第 2 天增加。在由局灶性 TSV 引起的 DCI 中,大脑中动脉平均速度(V)从发病第 4 天的 45.00±15.12cm/秒增加至 80.37±38.33cm/秒,同时 Pbto 从 29.09±17.88mmHg 降至 22.66±8.19mmHg。TSV 峰值(第 7-12 天)与 Pbto 下降同时发生。与尼莫地平相比,尼卡地平在 TSV 峰值时降低了 Lbo,具有生存获益(P<0.01)。静脉和脑池尼卡地平联合应用具有生存获益(Cramer Φ=0.43 和 0.327;G=28.32;P<0.001)。本研究在生存获益期间确定了 4 个 Lbo 区域(Cramer Φ=0.43 和 0.3)TSV,未代偿;全脑缺血,代偿和正常 Pbto。发病时格拉斯哥昏迷量表评分(未增加 ICP)可预测较低的 Pbto(β=0.812,R=0.661,F=58.41;P<0.0001)。昏迷是唯一可信的死亡预测因素(比值比,7.33/>4.8*;χ=7.556;置信区间,1.70-31.54;P<0.01),其次是基底动脉瘤、较差的分级、高 ICP 和 TSV 时的 Lbo。全脑缺血发生在发病后即刻,尽管治疗强度水平较高,但仍有 30%的患者持续存在,随后是 TSV 期间的 DCI。
我们提出了一些临床实践和患者管理方面的建议,以尽量减少脑缺血的发生。